Cargando…
Observations on the use of Bruton’s tyrosine kinase inhibitors in SAR-CoV-2 and cancer
Bruton’s tyrosine kinase (BTK) inhibitors, drugs utilized in cancer, are being repurposed for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (COVID-19). Recently, BTK inhibitors acalabrutinib and ibrutinib have been found to protect against pulmonary injury in a small group of patients...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805262/ https://www.ncbi.nlm.nih.gov/pubmed/33441177 http://dx.doi.org/10.1186/s13045-020-00999-8 |